Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle

Curtis A. Nutter, Elizabeth Jaworski, Sunil K. Verma, Yareli Perez-Carrasco, Neslihan Martinez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Type 1 diabetic patients can develop skeletal muscle weakness and atrophy by molecular mechanisms that are not well understood. Alternative splicing (AS) is critical for gene expression in the skeletal muscle, and its dysregulation is implicated in muscle weakness and atrophy. Therefore, we investigated whether AS patterns are affected in type 1 diabetic skeletal muscle contributing to skeletal muscle defects. Methods: AS patterns were determined by reverse transcription-polymerase chain reaction and levels of RNA binding proteins were assessed by Western blot in type 1 diabetic mouse skeletal muscle and during normal mouse skeletal muscle development. Results: Five genes with critical functions in the skeletal muscle are misspliced in type 1 diabetic skeletal muscle, resembling their AS patterns at embryonic stages. AS of these genes undergoes dramatic transitions during skeletal muscle development, correlating with changes in specific RNA binding proteins. Conclusion: Embryonic spliced variants are inappropriately expressed in type 1 diabetic skeletal muscle.

Original languageEnglish (US)
JournalMuscle and Nerve
DOIs
StateAccepted/In press - 2017

Fingerprint

Alternative Splicing
Skeletal Muscle
RNA-Binding Proteins
Muscular Atrophy
Muscle Development
Muscle Weakness
Genes
Reverse Transcription
Western Blotting
Gene Expression
Polymerase Chain Reaction

Keywords

  • Alternative splicing
  • Muscle development
  • RNA binding proteins
  • Skeletal muscle
  • Type 1 diabetes

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle. / Nutter, Curtis A.; Jaworski, Elizabeth; Verma, Sunil K.; Perez-Carrasco, Yareli; Martinez, Neslihan.

In: Muscle and Nerve, 2017.

Research output: Contribution to journalArticle

Nutter, Curtis A. ; Jaworski, Elizabeth ; Verma, Sunil K. ; Perez-Carrasco, Yareli ; Martinez, Neslihan. / Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle. In: Muscle and Nerve. 2017.
@article{c38146c8da5e4705ad28529f5c99f58e,
title = "Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle",
abstract = "Introduction: Type 1 diabetic patients can develop skeletal muscle weakness and atrophy by molecular mechanisms that are not well understood. Alternative splicing (AS) is critical for gene expression in the skeletal muscle, and its dysregulation is implicated in muscle weakness and atrophy. Therefore, we investigated whether AS patterns are affected in type 1 diabetic skeletal muscle contributing to skeletal muscle defects. Methods: AS patterns were determined by reverse transcription-polymerase chain reaction and levels of RNA binding proteins were assessed by Western blot in type 1 diabetic mouse skeletal muscle and during normal mouse skeletal muscle development. Results: Five genes with critical functions in the skeletal muscle are misspliced in type 1 diabetic skeletal muscle, resembling their AS patterns at embryonic stages. AS of these genes undergoes dramatic transitions during skeletal muscle development, correlating with changes in specific RNA binding proteins. Conclusion: Embryonic spliced variants are inappropriately expressed in type 1 diabetic skeletal muscle.",
keywords = "Alternative splicing, Muscle development, RNA binding proteins, Skeletal muscle, Type 1 diabetes",
author = "Nutter, {Curtis A.} and Elizabeth Jaworski and Verma, {Sunil K.} and Yareli Perez-Carrasco and Neslihan Martinez",
year = "2017",
doi = "10.1002/mus.25599",
language = "English (US)",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle

AU - Nutter, Curtis A.

AU - Jaworski, Elizabeth

AU - Verma, Sunil K.

AU - Perez-Carrasco, Yareli

AU - Martinez, Neslihan

PY - 2017

Y1 - 2017

N2 - Introduction: Type 1 diabetic patients can develop skeletal muscle weakness and atrophy by molecular mechanisms that are not well understood. Alternative splicing (AS) is critical for gene expression in the skeletal muscle, and its dysregulation is implicated in muscle weakness and atrophy. Therefore, we investigated whether AS patterns are affected in type 1 diabetic skeletal muscle contributing to skeletal muscle defects. Methods: AS patterns were determined by reverse transcription-polymerase chain reaction and levels of RNA binding proteins were assessed by Western blot in type 1 diabetic mouse skeletal muscle and during normal mouse skeletal muscle development. Results: Five genes with critical functions in the skeletal muscle are misspliced in type 1 diabetic skeletal muscle, resembling their AS patterns at embryonic stages. AS of these genes undergoes dramatic transitions during skeletal muscle development, correlating with changes in specific RNA binding proteins. Conclusion: Embryonic spliced variants are inappropriately expressed in type 1 diabetic skeletal muscle.

AB - Introduction: Type 1 diabetic patients can develop skeletal muscle weakness and atrophy by molecular mechanisms that are not well understood. Alternative splicing (AS) is critical for gene expression in the skeletal muscle, and its dysregulation is implicated in muscle weakness and atrophy. Therefore, we investigated whether AS patterns are affected in type 1 diabetic skeletal muscle contributing to skeletal muscle defects. Methods: AS patterns were determined by reverse transcription-polymerase chain reaction and levels of RNA binding proteins were assessed by Western blot in type 1 diabetic mouse skeletal muscle and during normal mouse skeletal muscle development. Results: Five genes with critical functions in the skeletal muscle are misspliced in type 1 diabetic skeletal muscle, resembling their AS patterns at embryonic stages. AS of these genes undergoes dramatic transitions during skeletal muscle development, correlating with changes in specific RNA binding proteins. Conclusion: Embryonic spliced variants are inappropriately expressed in type 1 diabetic skeletal muscle.

KW - Alternative splicing

KW - Muscle development

KW - RNA binding proteins

KW - Skeletal muscle

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85017535158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017535158&partnerID=8YFLogxK

U2 - 10.1002/mus.25599

DO - 10.1002/mus.25599

M3 - Article

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

ER -